A prospective single-centre study found that 97 percent of 304 outpatients with low-risk drug allergy labels had no reaction ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results